×

Evolocumab

Medication
Evolocumab, sold under the brand name Repatha, is a monoclonal antibody that is an immunotherapy medication for the treatment of hyperlipidemia. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin... Wikipedia
AHFS/Drugs.com: Monograph
ATC code: C10AX13 (WHO)
License data: US DailyMed: Evolocumab
Pregnancy category: AU: B1
Pronunciation: EE-voh-lock-yoo-mab
Routes of administration: Subcutaneous
Source: Human

People also ask
Repatha® is an injectable prescription medicine used: in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain ...
Repatha® is an injectable prescription medicine used: in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain ...
Repatha® enhances removal of LDL-cholesterol by inhibiting PCSK9, increasing the number of LDL receptors on the surface of the liver, resulting in reduction of ...
what is repatha from www.drugs.com
Sep 25, 2023 · Repatha (evolocumab) is a PCSK9 inhibitor used for hypercholesterolemia (high cholesterol) and cardiovascular risk reduction.
what is repatha from www.medicalnewstoday.com
Repatha (evolocumab) is used to treat high cholesterol and to reduce risks in people with heart disease. Learn about side effects, cost, and more.
Considering taking Repatha® with a statin as a treatment option for lowering your high LDL? Learn how Repatha can help. See Full Safety & Prescribing Info.
Feb 1, 2024 · Evolocumab injection is used together with a proper diet, alone or together with other medicines (eg, ezetimibe, statins), to treat patients ...
what is repatha from www.healthline.com
Repatha (evolocumab) is a prescription drug that's used in certain situations to decrease serious heart-related risks and lower cholesterol.
Overview. Repatha is a medicine for lowering levels of fats in the blood. It is used to reduce blood fat levels in patients with primary ...
Immunogenicity: Repatha® is a human monoclonal antibody. As with all therapeutic proteins, there is potential for immunogenicity with Repatha®.